In this issue:
- Comorbidity and safety of biologic therapy in older adults
- Reinduction and/or dose escalation of ustekinumab in CD
- Earlier anti-TNF initiation and long-term health care utilisation in IBD
- FMT with anti-inflammatory diet for UC
- Faecal myeloperoxidase as a biomarker of endoscopic activity in IBD
- IBD-associated colorectal cancer
- Adrenomedullin for biologic resistant CD
- Obefazimod for moderate-to-severe active UC
- Fatigue in adults with IBD
- Mindfulness-based cognitive therapy for fatigue in IBD
- Science blog: Identifying IBD specific T cell subsets
Please login below to download this issue (PDF)